Qrem — Seed · €1M

Tecnología Regenerativa Qrem SL develops 'Lab-in-a-Box' devices for regenerative medicine; its first product, Q-Cytokine, produces a cytokine-rich serum from the patient's own blood. Inveready put in €500K through Inveready Biotech III, and the business angels who backed the company from the start supplied the rest. The money goes to clinical validation and a bigger sales team.